Sofie Biosciences, Inc.
CULVER CITY, CA · Founded 2009 · CIK 0001590830 · Medtech · Private
Multi-site infrastructure and standardized synthesis platform for clinical-grade PET (positron emission tomography) probes and radiolabeled molecular imaging agents
sofie.com →- Grants
- $7.7M
- 8 awards
- Sector median: 1
- Raised
- $9.7M
- 4 Form D · Jul 2019
- 86 months since last filing
- Contracts
- $1.7M
- 3 awards · Health and Human S
- #240 of 4531 in medtech
- Patents
- 4
- 2 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201220132014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Other Functions - A Novel Pet Probe For Use In Cancer Diagnostics | $250,000 | |
| Private capital raised | Form D · SEC | $5,000,004 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf A Novel Pet Probe For Use In Cancer Diagnosispop: 09/19/2014 To 09/18/2016 | $1,481,282 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of a Benchtop Radiosynthesizer for the Production of PET Probes | $588,958 | |
| Private capital raised | Form D · SEC | $3,700,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Fully automated enzymatic radiolabeling of biomolecules | $149,800 | |
| Private capital raised | Form D · SEC | $16,752,250 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of a benchtop radiosynthesizer for the production of PET probes | $1,999,603 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel PET Probe for Use in Cancer Diagnostics | $1,997,079 | |
| Federal contract | Department of Health and Human Services · Repair Of Computer Controller For Sofie Biosystems G4 System | $7,100 | |
| Federal grant | Department of Health and Human Services · Phase II · Fully automated enzymatic radiolabeling of biomolecules | $501,151 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · A Novel PET Probe for Use in Cancer Diagnostics | $999,412 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Commercialization of a benchtop radiosynthesizer for the production of PET probes | $1,002,183 | |
| Private capital raised | Form D · SEC | $950,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Fully automated enzymatic radiolabeling of biomolecules | $501,281 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 237 | Particle Metrix | $1.8M | — |
| 238 | ROSELLINI SCIENTIFIC, LLC | $1.8M | — |
| 239 | HELIOWAVE TECHNOLOGIES LLC | $1.7M | — |
| 240 | Sofie Biosciences, Inc. | $1.7M | $9.7M |
| 241 | CytoViva Inc | $1.7M | $785K |
| 242 | DIAPEDIA, LLC | $1.7M | — |
| 243 | Evoke Neuroscience, Inc. | $1.7M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Stan BermanExecutive Officer
- Joel CohenExecutive Officer
- Johannes CzerninDirector
- Philipp CzerninExecutive Officer
- Roy DoumaniDirector
- James HeathDirector
- Ken Hermann, M.D.Director
- K. JudsonDirector
- Howard MaronDirector
- Carl McKinzieDirector
- Melissa Moore, Ph.DExecutive Officer
- Michael PhelpsDirector
- Patrick PhelpsDirector · Executive Officer
- Ajit SinghDirector
Patents
- Automated Purification And Formulation Device For Radiopharmaceutical Compoundsgranted
- Self-shielded, Benchtop Radio Chemistry System With A Plurality Shielded Carriers Containing A Disposable Chip Cassettegranted
- Automated Purification And Formulation Module For Pet Probesapplication
- Self-shielded, Benchtop Chemistry Systemapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.